Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries)
- 1 December 2007
- journal article
- research article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 11, S29-S35
- https://doi.org/10.1016/s1201-9712(07)60019-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus VaccineNew England Journal of Medicine, 2006
- Burden of Rotavirus Disease in European Union CountriesThe Pediatric Infectious Disease Journal, 2006
- Novel Rotavirus VP7 Typing Assay Using a One-Step Reverse Transcriptase PCR Protocol and Product Sequencing and Utility of the Assay for Epidemiological Studies and Strain Characterization, Including Serotype Subgroup AnalysisJournal of Clinical Microbiology, 2005
- Rotavirus vaccines: past, present, and futureArchives de Pédiatrie, 2005
- Comparative Practice Patterns of Emergency Medicine Physicians and Pediatric Emergency Medicine Physicians Managing Fever in Young ChildrenPediatrics, 2001
- Efficacy of the Rhesus Rotavirus–Based Quadrivalent Vaccine in Infants and Young Children in VenezuelaNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsNew England Journal of Medicine, 1996
- Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central AfricaResearch in Virology, 1991
- TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTSThe Lancet, 1987